China Resources Medical Holdings Company Ltd (CR Medical, HKG: 1515) has published its 2024 financial report. The company recorded revenues of RMB 9.86 billion (USD 1.4 billion), marking a 2.5% year-on-year (YOY) decrease. Despite the revenue decline, net profits rose significantly by 104.9% YOY to RMB 672 million (USD 92.5 million).
Operational Overview
As of December 31, 2024, CR Medical managed and operated 105 medical institutions across 10 provinces and cities in China. The company’s outpatient and inpatient volumes for routine diagnosis and treatment at its owned hospitals were approximately 10.32 million and 560,000 patients respectively, representing a 1.9% and 1.0% YOY increase.
Business Segment Performance
The hospital business division reported revenues of RMB 9.185 billion (USD 1.3 billion), a 2.4% YOY decrease. This decline was attributed to the impact of medical insurance cost control, which led to a 2.4% and 4.3% decrease in average income from outpatient and inpatient visits respectively.-Fineline Info & Tech
Leave a Reply